Effects of early and adequate use of hormone combined with mortethaphenolate on the efficacy and prognosis of patients with proliferative lupus nephritis
XIAO Liyan1 CHEN Yong1▲ WANG Aiguo2
1.Department of Internal Medicine, the People′s Hospital of Kaizhou District Chongqing 405400, China;
2.Department of Infectious Diseases, the People′s Hospital of Kaizhou District CQ, Chongqing 405400, China
Abstract：Objective To analyze the effect of early and sufficient application of hormone combined with mortethaphenolate on the efficacy and prognosis of patients with proliferative lupus nephritis. Methods From April 2016 to October 2017, 92 patients with proliferative lupus nephritis admitted and treated in the Department of Internal Medicine of the People′s Hospital of Kaizhou District Chongqing were selected and divided into two groups according to the random number table method, 46 patients in each group. The control group was treated with adequate Hormone and Cyclophosphamide at the early stage, and the observation group was treated with adequate Hormone combined with Motimecophenolate at the early stage, and the clinical effects of the two groups were compared. Results Compared with the control group, the total effective rate was significantly increased in the observation group (P ＜ 0.05), and the results of urea nitrogen, serum creatinine level and 24 h urine protein quantification after treatment were lower than the control group, with statistically significant differences (P ＜ 0.05). The total incidence of adverse reactions in the observation group was significantly lower than that in the control group (P ＜ 0.05). After 1 year follow-up, the recurrence rate of renal disease in the observation group was significantly lower than that in the control group (P ＜ 0.05). Conclusion Early and sufficient application of Hormone combined with Morteofloxacin has a significant effect on proliferative lupus nephritis, which can improve the renal function of patients, reduce the risk of renal recurrence, and the drug safety is relatively high.
肖李艳1 陈勇1▲ 王爱国2. 早期、足量应用激素联合吗替麦考酚酯对增殖性狼疮性肾炎患者疗效及预后的影响[J]. 中国医药导报, 2019, 16(12): 58-61.
XIAO Liyan1 CHEN Yong1▲ WANG Aiguo2. Effects of early and adequate use of hormone combined with mortethaphenolate on the efficacy and prognosis of patients with proliferative lupus nephritis. 中国医药导报, 2019, 16(12): 58-61.
2019, Vol. 16 
京公网安备 11010502046598号